A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients
Clinical trial NCT03801798 · UNKNOWN
Trial details
- NCT number
- NCT03801798
- Sponsor
- Green Cross Corporation
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-11
- Primary completion
- 2021-12-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.